{"eu_number": "EU-1-01-178", "parse_date": "2022-12-28 18:24:48.102749", "decisions": [{"pdf_file": "EU-1-01-178_h_dec_0.pdf", "eu_aut_date": "2001-03-29", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "__SCRAPER_NOT_FOUND__", "eu_mah_initial": "Ligand Pharmaceuticals UK Ltd", "eu_aut_type_initial": "attribute not available on release", "eu_aut_type_current": "Not parsed"}, {"pdf_file": "EU-1-01-178_h_dec_1.pdf", "eu_aut_date": "2002-11-07", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "attribute not available on release", "eu_mah_current": "Ligand Pharmaceuticals UK Ltd"}, {"pdf_file": "EU-1-01-178_h_dec_10.pdf", "eu_aut_date": "2009-08-21", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai Limited"}, {"pdf_file": "EU-1-01-178_h_dec_11.pdf", "eu_aut_date": "2015-04-13", "eu_brand_name_initial": "Targretin", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai Limited"}, {"pdf_file": "EU-1-01-178_h_dec_12.pdf", "eu_aut_date": "2015-05-27", "eu_brand_name_initial": "Targretin", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai Limited"}, {"pdf_file": "EU-1-01-178_h_dec_13.pdf", "eu_aut_date": "2018-06-21", "eu_brand_name_initial": ", medicinal product for human use  (Text with EEA relevance) (ONLY THE ENGLISH TEXT IS AUTHENTIC)     EN 1   EN COMMISSION IMPLEMENTING DECISION  21.6.2018  concerning, in the framework  Article 31  Directive 2001/83/EC  the European  Parliament and  the Council, the marketing authorisation granted by Decision  C(2001)818 for \u201cTargretin", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai Limited"}, {"pdf_file": "EU-1-01-178_h_dec_14.pdf", "eu_aut_date": "2018-09-17", "eu_brand_name_initial": "Targretin", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai Limited"}, {"pdf_file": "EU-1-01-178_h_dec_15.pdf", "eu_aut_date": "2019-07-11", "eu_brand_name_initial": "Targretin", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai GmbH"}, {"pdf_file": "EU-1-01-178_h_dec_16.pdf", "eu_aut_date": "2021-06-21", "eu_brand_name_initial": "Targretin", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": false, "eu_atmp": false, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai GmbH"}, {"pdf_file": "EU-1-01-178_h_dec_2.pdf", "eu_aut_date": "2002-10-17", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "attribute not available on release", "eu_mah_current": "Ligand Pharmaceuticals UK Ltd"}, {"pdf_file": "EU-1-01-178_h_dec_3.pdf", "eu_aut_date": "2003-04-06", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "attribute not available on release", "eu_mah_current": "Ligand Pharmaceuticals UK Ltd"}, {"pdf_file": "EU-1-01-178_h_dec_4.pdf", "eu_aut_date": "2004-11-17", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "attribute not available on release", "eu_mah_current": "Ligand Pharmaceuticals UK Ltd"}, {"pdf_file": "EU-1-01-178_h_dec_5.pdf", "eu_aut_date": "2006-04-24", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Ligand Pharmaceuticals UK Ltd"}, {"pdf_file": "EU-1-01-178_h_dec_6.pdf", "eu_aut_date": "2007-01-26", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Ligand Pharmaceuticals UK Ltd"}, {"pdf_file": "EU-1-01-178_h_dec_7.pdf", "eu_aut_date": "2004-11-04", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "attribute not available on release", "eu_mah_current": "Ligand Pharmaceuticals UK Ltd"}, {"pdf_file": "EU-1-01-178_h_dec_8.pdf", "eu_aut_date": "2007-11-12", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": "attribute not available on release", "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai Limited"}, {"pdf_file": "EU-1-01-178_h_dec_9.pdf", "eu_aut_date": "2008-08-25", "eu_brand_name_initial": "TARGRETIN", "eu_brand_name_current": "Not parsed", "active_substance": "bexarotene", "eu_nas": "attribute not available on release", "eu_atmp": true, "eu_od_initial": "Not parsed", "eu_mah_initial": "Not parsed", "eu_aut_type_initial": "Not parsed", "eu_aut_type_current": "__SCRAPER_NOT_FOUND__", "eu_mah_current": "Eisai Limited"}], "annexes": [{"pdf_file": "EU-1-01-178_h_anx_0.pdf", "xml_file": "EU-1-01-178_h_anx_0.xml", "is_initial": true, "creation_date": "D:20070920103613+02'00'", "modification_date": "D:20070920103615+02'00'", "eu_aut_type_initial": "standard", "eu_med_type": "small molecule", "eu_indication_initial": "targretin capsules are indicated for the treatment of skin manifestations of advanced stage ctcl patients refractory to at least one systemic treatment.\n"}, {"pdf_file": "EU-1-01-178_h_anx_1.pdf", "xml_file": "EU-1-01-178_h_anx_1.xml", "is_initial": false, "creation_date": "D:20020705163035Z", "modification_date": "D:20060321214253+01'00'"}, {"pdf_file": "EU-1-01-178_h_anx_10.pdf", "xml_file": "EU-1-01-178_h_anx_10.xml", "is_initial": false, "creation_date": "D:20090318150750Z", "modification_date": "D:20090403125803+01'00'"}, {"pdf_file": "EU-1-01-178_h_anx_11.pdf", "xml_file": "EU-1-01-178_h_anx_11.xml", "is_initial": false, "creation_date": "D:20141002153341+01'00'", "modification_date": "D:20141007081207-04'00'"}, {"pdf_file": "EU-1-01-178_h_anx_12.pdf", "xml_file": "EU-1-01-178_h_anx_12.xml", "is_initial": false, "creation_date": "D:20150420185435+01'00'", "modification_date": "D:20150420185824+01'00'"}, {"pdf_file": "EU-1-01-178_h_anx_13.pdf", "xml_file": "EU-1-01-178_h_anx_13.xml", "is_initial": false, "creation_date": "D:20180611154241+01'00'", "modification_date": "D:20180611162308+01'00'"}, {"pdf_file": "EU-1-01-178_h_anx_14.pdf", "xml_file": "EU-1-01-178_h_anx_14.xml", "is_initial": false, "creation_date": "D:20180821105704-04'00'", "modification_date": "D:20180821164434-04'00'"}, {"pdf_file": "EU-1-01-178_h_anx_15.pdf", "xml_file": "EU-1-01-178_h_anx_15.xml", "is_initial": false, "creation_date": "D:20181123084105-05'00'", "modification_date": "D:20181123095121-05'00'"}, {"pdf_file": "EU-1-01-178_h_anx_16.pdf", "xml_file": "EU-1-01-178_h_anx_16.xml", "is_initial": false, "creation_date": "D:20210414071759-04'00'", "modification_date": "D:20210429075535-04'00'"}, {"pdf_file": "EU-1-01-178_h_anx_2.pdf", "xml_file": "EU-1-01-178_h_anx_2.xml", "is_initial": false, "creation_date": "D:20021021094835Z", "modification_date": "D:20060321223132+01'00'"}, {"pdf_file": "EU-1-01-178_h_anx_3.pdf", "xml_file": "EU-1-01-178_h_anx_3.xml", "is_initial": false, "creation_date": "D:20030523155212", "modification_date": "D:20030523155219+02'00'"}, {"pdf_file": "EU-1-01-178_h_anx_4.pdf", "xml_file": "EU-1-01-178_h_anx_4.xml", "is_initial": false, "creation_date": "D:20041018141855+01'00'", "modification_date": "D:20041018141855+01'00'"}, {"pdf_file": "EU-1-01-178_h_anx_5.pdf", "xml_file": "EU-1-01-178_h_anx_5.xml", "is_initial": false, "creation_date": "D:20060320154359Z", "modification_date": "D:20060322100217Z"}, {"pdf_file": "EU-1-01-178_h_anx_6.pdf", "xml_file": "EU-1-01-178_h_anx_6.xml", "is_initial": false, "creation_date": "D:20070112134218Z", "modification_date": "D:20070112135544Z"}, {"pdf_file": "EU-1-01-178_h_anx_7.pdf", "xml_file": "EU-1-01-178_h_anx_7.xml", "is_initial": false, "creation_date": "D:20070319161459Z", "modification_date": "D:20070319164758Z"}, {"pdf_file": "EU-1-01-178_h_anx_8.pdf", "xml_file": "EU-1-01-178_h_anx_8.xml", "is_initial": false, "creation_date": "D:20071109101658Z", "modification_date": "D:20071112140822Z"}, {"pdf_file": "EU-1-01-178_h_anx_9.pdf", "xml_file": "EU-1-01-178_h_anx_9.xml", "is_initial": false, "creation_date": "D:20080815130539+01'00'", "modification_date": "D:20080815130541+01'00'"}], "epars": [{"pdf_file": "EU-1-01-178_h_public-assessment-report.pdf", "ema_procedure_start_initial": "__SCRAPER_NOT_FOUND__", "chmp_opinion_date": "__SCRAPER_NOT_FOUND__", "eu_legal_basis": ["__SCRAPER_NOT_FOUND__"], "eu_prime_initial": "False", "ema_rapp": "__SCRAPER_NOT_FOUND__", "ema_corapp": "__SCRAPER_NOT_FOUND__", "ema_reexamination": "False", "eu_accel_assess_g": "False"}], "omars": [], "odwars": []}